Rise in alanine aminotransferase after HCV treatment is a highly sensitive screen for treatment failure.

Saved in:
Bibliographic Details
Title: Rise in alanine aminotransferase after HCV treatment is a highly sensitive screen for treatment failure.
Authors: Flower B; Department of CNS Infection, HIV and Viral Hepatitis, Oxford University Clinical Research Unit (OUCRU), Ho Chi Minh City, Vietnam.; Department of Infectious Disease, Imperial College London, London, UK., Nguyen Thi Ngoc P; Department of CNS Infection, HIV and Viral Hepatitis, Oxford University Clinical Research Unit (OUCRU), Ho Chi Minh City, Vietnam., McCabe L; MRC Clinical Trials Unit at UCL, University College London, London, UK., Le Ngoc C; Department of CNS Infection, HIV and Viral Hepatitis, Oxford University Clinical Research Unit (OUCRU), Ho Chi Minh City, Vietnam., Vo Thi T; Department of CNS Infection, HIV and Viral Hepatitis, Oxford University Clinical Research Unit (OUCRU), Ho Chi Minh City, Vietnam., Thi Kim HV; Department of CNS Infection, HIV and Viral Hepatitis, Oxford University Clinical Research Unit (OUCRU), Ho Chi Minh City, Vietnam., Dang Trong T; Department of CNS Infection, HIV and Viral Hepatitis, Oxford University Clinical Research Unit (OUCRU), Ho Chi Minh City, Vietnam., Rahman M; Department of CNS Infection, HIV and Viral Hepatitis, Oxford University Clinical Research Unit (OUCRU), Ho Chi Minh City, Vietnam.; Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, Oxford University, Oxford, UK., Thwaites G; Department of CNS Infection, HIV and Viral Hepatitis, Oxford University Clinical Research Unit (OUCRU), Ho Chi Minh City, Vietnam.; Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, Oxford University, Oxford, UK., Walker AS; MRC Clinical Trials Unit at UCL, University College London, London, UK.; Nuffield Department of Medicine, University of Oxford, Oxford, UK.; The National Institute for Health Research, Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Hung LM; Department of Hepatology, Hospital for Tropical Diseases, Ho Chi Minh City., Vinh Chau NV; Department of Hepatology, Hospital for Tropical Diseases, Ho Chi Minh City., Cooke GS; Department of Infectious Disease, Imperial College London, London, UK., Day JN; Department of CNS Infection, HIV and Viral Hepatitis, Oxford University Clinical Research Unit (OUCRU), Ho Chi Minh City, Vietnam.; Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, Oxford University, Oxford, UK.
Source: Clinical liver disease [Clin Liver Dis (Hoboken)] 2023 May 31; Vol. 21 (5), pp. 138-142. Date of Electronic Publication: 2023 May 31 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 101597441 Publication Model: eCollection Cited Medium: Print ISSN: 2046-2484 (Print) Linking ISSN: 20462484 NLM ISO Abbreviation: Clin Liver Dis (Hoboken) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2046-2484
DOI:10.1097/CLD.0000000000000055